Journal articles on the topic 'T1AM'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'T1AM.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Rogowski, Michael, Lorenza Bellusci, Martina Sabatini, et al. "Lipolytic Effects of 3-Iodothyronamine (T1AM) and a Novel Thyronamine-Like Analog SG-2 through the AMPK Pathway." International Journal of Molecular Sciences 20, no. 16 (2019): 4054. http://dx.doi.org/10.3390/ijms20164054.
Full textSaba, Alessandro, Grazia Chiellini, Sabina Frascarelli, et al. "Tissue Distribution and Cardiac Metabolism of 3-Iodothyronamine." Endocrinology 151, no. 10 (2010): 5063–73. http://dx.doi.org/10.1210/en.2010-0491.
Full textDinter, Juliane, Noushafarin Khajavi, Jessica Mühlhaus та ін. "The Multitarget Ligand 3-Iodothyronamine Modulates β-Adrenergic Receptor 2 Signaling". European Thyroid Journal 4, Suppl. 1 (2015): 21–29. http://dx.doi.org/10.1159/000381801.
Full textGhelardoni, Sandra, Grazia Chiellini, Sabina Frascarelli, Alessandro Saba, and Riccardo Zucchi. "Uptake and metabolic effects of 3-iodothyronamine in hepatocytes." Journal of Endocrinology 221, no. 1 (2014): 101–10. http://dx.doi.org/10.1530/joe-13-0311.
Full textDinter, Juliane, Jessica Mühlhaus, Simon Friedrich Jacobi та ін. "3-iodothyronamine differentially modulates α-2A-adrenergic receptor-mediated signaling". Journal of Molecular Endocrinology 54, № 3 (2015): 205–16. http://dx.doi.org/10.1530/jme-15-0003.
Full textHaiyan, Zhou, Hu Bailong, Zhang Bei, Wang Yiming, and Liu Xingde. "Comparative Transcriptome Analysis Reveals the Potential Cardiovascular Protective Targets of the Thyroid Hormone Metabolite 3-Iodothyronamine (3-T1AM)." BioMed Research International 2020 (June 20, 2020): 1–10. http://dx.doi.org/10.1155/2020/1302453.
Full textCöster, Maxi, Heike Biebermann, Torsten Schöneberg, and Claudia Stäubert. "Evolutionary Conservation of 3-Iodothyronamine as an Agonist at the Trace Amine-Associated Receptor 1." European Thyroid Journal 4, Suppl. 1 (2015): 9–20. http://dx.doi.org/10.1159/000430839.
Full textGencarelli, Manuela, Annunziatina Laurino, Elisa Landucci, et al. "3-Iodothyronamine Affects Thermogenic Substrates’ Mobilization in Brown Adipocytes." Biology 9, no. 5 (2020): 95. http://dx.doi.org/10.3390/biology9050095.
Full textGalli, Elena, Maja Marchini, Alessandro Saba, et al. "Detection of 3-Iodothyronamine in Human Patients: A Preliminary Study." Journal of Clinical Endocrinology & Metabolism 97, no. 1 (2012): E69—E74. http://dx.doi.org/10.1210/jc.2011-1115.
Full textHackenmueller, Sarah A., Maja Marchini, Alessandro Saba, Riccardo Zucchi, and Thomas S. Scanlan. "Biosynthesis of 3-Iodothyronamine (T1AM) Is Dependent on the Sodium-Iodide Symporter and Thyroperoxidase but Does Not Involve Extrathyroidal Metabolism of T4." Endocrinology 153, no. 11 (2012): 5659–67. http://dx.doi.org/10.1210/en.2012-1254.
Full textAgretti, Patrizia, Giuseppina De Marco, Laura Russo, et al. "3-Iodothyronamine metabolism and functional effects in FRTL5 thyroid cells." Journal of Molecular Endocrinology 47, no. 1 (2011): 23–32. http://dx.doi.org/10.1530/jme-10-0168.
Full textScanlan, Thomas S. "3-Iodothyronamine (T1AM): A New Player on the Thyroid Endocrine Team?" Endocrinology 150, no. 3 (2008): 1108–11. http://dx.doi.org/10.1210/en.2008-1596.
Full textGencarelli, Manuela, Maura Lodovici, Lorenza Bellusci, Laura Raimondi, and Annunziatina Laurino. "Redox Properties of 3-Iodothyronamine (T1AM) and 3-Iodothyroacetic Acid (TA1)." International Journal of Molecular Sciences 23, no. 5 (2022): 2718. http://dx.doi.org/10.3390/ijms23052718.
Full textAckermans, M. T., L. P. Klieverik, P. Ringeling, E. Endert, A. Kalsbeek, and E. Fliers. "An online solid-phase extraction–liquid chromatography–tandem mass spectrometry method to study the presence of thyronamines in plasma and tissue and their putative conversion from 13C6-thyroxine." Journal of Endocrinology 206, no. 3 (2010): 327–34. http://dx.doi.org/10.1677/joe-10-0060.
Full textRutigliano, Grazia, Lavinia Bandini, Simona Sestito, and Grazia Chiellini. "3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome?" International Journal of Molecular Sciences 21, no. 6 (2020): 2005. http://dx.doi.org/10.3390/ijms21062005.
Full textdi Leo, Nicoletta, Stefania Moscato, Marco Borso', et al. "Delivery of Thyronamines (TAMs) to the Brain: A Preliminary Study." Molecules 26, no. 6 (2021): 1616. http://dx.doi.org/10.3390/molecules26061616.
Full textBandini, Lavinia, Ginevra Sacripanti, Marco Borsò, et al. "Exogenous 3-Iodothyronamine (T1AM) Can Affect Phosphorylation of Proteins Involved on Signal Transduction Pathways in In Vitro Models of Brain Cell Lines, but These Effects Are Not Strengthened by Its Catabolite, 3-Iodothyroacetic Acid (TA1)." Life 12, no. 9 (2022): 1352. http://dx.doi.org/10.3390/life12091352.
Full textBiebermann, Heike, and Gunnar Kleinau. "3-Iodothyronamine Induces Diverse Signaling Effects at Different Aminergic and Non-Aminergic G-Protein Coupled Receptors." Experimental and Clinical Endocrinology & Diabetes 128, no. 06/07 (2019): 395–400. http://dx.doi.org/10.1055/a-1022-1554.
Full textHoefig, Carolin S., Tilo Wuensch, Eddy Rijntjes, et al. "Biosynthesis of 3-Iodothyronamine From T4 in Murine Intestinal Tissue." Endocrinology 156, no. 11 (2015): 4356–64. http://dx.doi.org/10.1210/en.2014-1499.
Full textChiellini, Grazia, Paola Erba, Vittoria Carnicelli, et al. "Distribution of exogenous [125I]-3-iodothyronamine in mouse in vivo: relationship with trace amine-associated receptors." Journal of Endocrinology 213, no. 3 (2012): 223–30. http://dx.doi.org/10.1530/joe-12-0055.
Full textWei, Bo, Hanbing Zhao, Bailong Hu, et al. "T1AM Attenuates the Hypoxia/Reoxygenation-Induced Necroptosis of H9C2 Cardiomyocytes via RIPK1/RIPK3 Pathway." BioMed Research International 2022 (February 28, 2022): 1–8. http://dx.doi.org/10.1155/2022/4833791.
Full textDiab, Nour, Sameer Desale, Mark Danielsen, Josef Köhrle, Nawar Shara, and Jacqueline Jonklaas. "Changes in Thyroid Metabolites after Liothyronine Administration: A Secondary Analysis of Two Clinical Trials That Incorporated Pharmacokinetic Data." Metabolites 12, no. 6 (2022): 476. http://dx.doi.org/10.3390/metabo12060476.
Full textKlieverik, Lars P., Ewout Foppen, Mariëtte T. Ackermans, et al. "Central effects of thyronamines on glucose metabolism in rats." Journal of Endocrinology 201, no. 3 (2009): 377–86. http://dx.doi.org/10.1677/joe-09-0043.
Full textHomuth, Georg, Julika Lietzow, Nancy Schanze, Janine Golchert, and Josef Köhrle. "Endocrine, Metabolic and Pharmacological Effects of Thyronamines (TAM), Thyroacetic Acids (TA) and Thyroid Hormone Metabolites (THM) – Evidence from in vitro, Cellular, Experimental Animal and Human Studies." Experimental and Clinical Endocrinology & Diabetes 128, no. 06/07 (2020): 401–13. http://dx.doi.org/10.1055/a-1139-9200.
Full textBellusci, Lorenza, Massimiliano Runfola, Vittoria Carnicelli, et al. "Endogenous 3-Iodothyronamine (T1AM) and Synthetic Thyronamine-Like Analog SG-2 Act as Novel Pleiotropic Neuroprotective Agents through the Modulation of SIRT6." Molecules 25, no. 5 (2020): 1054. http://dx.doi.org/10.3390/molecules25051054.
Full textScanlan, Thomas S. "Endogenous 3-Iodothyronamine (T1AM): More Than We Bargained For." Journal of Clinical Endocrinology & Metabolism 96, no. 6 (2011): 1674–76. http://dx.doi.org/10.1210/jc.2011-0688.
Full textLaurino, Annunziatina, Rosanna Matucci, Giulio Vistoli, and Laura Raimondi. "3-iodothyronamine (T1AM), a novel antagonist of muscarinic receptors." European Journal of Pharmacology 793 (December 2016): 35–42. http://dx.doi.org/10.1016/j.ejphar.2016.10.027.
Full textStavrou, Stavroula, Michael Gratz, Eileen Tremmel та ін. "TAAR1 induces a disturbed GSK3β phosphorylation in recurrent miscarriages through the ODC". Endocrine Connections 7, № 2 (2018): 372–84. http://dx.doi.org/10.1530/ec-17-0272.
Full textMiyakawa, Motonori, and Thomas S. Scanlan. "Synthesis of [125I]‐, [2H]‐, and [3H]‐Labeled 3‐Iodothyronamine (T1AM)." Synthetic Communications 36, no. 7 (2006): 891–902. http://dx.doi.org/10.1080/00397910500466074.
Full textIanculescu, Alexandra G., and Thomas S. Scanlan. "3-Iodothyronamine (T1AM): a new chapter of thyroid hormone endocrinology?" Molecular BioSystems 6, no. 8 (2010): 1338. http://dx.doi.org/10.1039/b926583j.
Full textGratz, Michael J., Stavroula Stavrou, Christina Kuhn, et al. "Dopamine synthesis and dopamine receptor expression are disturbed in recurrent miscarriages." Endocrine Connections 7, no. 5 (2018): 727–38. http://dx.doi.org/10.1530/ec-18-0126.
Full textTozzi, Francesca, Grazia Rutigliano, Marco Borsò, Chiara Falcicchia, Riccardo Zucchi, and Nicola Origlia. "T1AM-TAAR1 signalling protects against OGD-induced synaptic dysfunction in the entorhinal cortex." Neurobiology of Disease 151 (April 2021): 105271. http://dx.doi.org/10.1016/j.nbd.2021.105271.
Full textla Cour, Jeppe Lerche, Heidi M. Christensen, Josef Köhrle, et al. "Association Between 3-Iodothyronamine (T1am) Concentrations and Left Ventricular Function in Chronic Heart Failure." Journal of Clinical Endocrinology & Metabolism 104, no. 4 (2018): 1232–38. http://dx.doi.org/10.1210/jc.2018-01466.
Full textChiellini, Grazia, Sandra Ghelardoni, Sabina Frascarelli, et al. "3-Iodothyronamine (T1AM) induces variation in phosphorylation pattern of tyrosine residues in rat heart." Journal of Molecular and Cellular Cardiology 44, no. 4 (2008): 773–74. http://dx.doi.org/10.1016/j.yjmcc.2008.02.149.
Full textGonçalves, Luís M., Manuela M. Moreira, Carla F. Azevedo, et al. "Proof of Concept of the Electrochemical Sensing of 3-Iodothyronamine (T1AM) and Thyronamine (T0AM)." ChemElectroChem 1, no. 10 (2014): 1623–26. http://dx.doi.org/10.1002/celc.201402165.
Full textLi, Zhong-Min, Manuel Miller, Sogol Gachkar, et al. "Determination of 3-iodothyronamine (3-T1AM) in mouse liver using liquid chromatography-tandem mass spectrometry." Journal of Chromatography B 1165 (February 2021): 122553. http://dx.doi.org/10.1016/j.jchromb.2021.122553.
Full textLangouche, Lies, Ina Lehmphul, Sarah Vander Perre, Josef Köhrle, and Greet Van den Berghe. "Circulating 3-T1AM and 3,5-T2 in Critically Ill Patients: A Cross-Sectional Observational Study." Thyroid 26, no. 12 (2016): 1674–80. http://dx.doi.org/10.1089/thy.2016.0214.
Full textLaurino, Annunziatina, Ersilia Lucenteforte, Gaetano De Siena, and Laura Raimondi. "The impact of scopolamine pretreatment on 3-iodothyronamine (T1AM) effects on memory and pain in mice." Hormones and Behavior 94 (August 2017): 93–96. http://dx.doi.org/10.1016/j.yhbeh.2017.07.003.
Full textLaurino, Annunziatina, Manuela Gencarelli, and Laura Raimondi. "The 3-iodothyronamine (T1AM) and the 3-iodothyroacetic acid (TA1) indicate a novel connection with the histamine system for neuroprotection." European Journal of Pharmacology 912 (December 2021): 174606. http://dx.doi.org/10.1016/j.ejphar.2021.174606.
Full textManni, Maria Elena, Gaetano De Siena, Alessandro Saba, et al. "Pharmacological effects of 3-iodothyronamine (T1AM) in mice include facilitation of memory acquisition and retention and reduction of pain threshold." British Journal of Pharmacology 168, no. 2 (2012): 354–62. http://dx.doi.org/10.1111/j.1476-5381.2012.02137.x.
Full textAssadi-Porter, Fariba, Hannah Reiland, Martina Sabatini, et al. "Metabolic Reprogramming by 3-Iodothyronamine (T1AM): A New Perspective to Reverse Obesity through Co-Regulation of Sirtuin 4 and 6 Expression." International Journal of Molecular Sciences 19, no. 5 (2018): 1535. http://dx.doi.org/10.3390/ijms19051535.
Full textLanducci, Elisa, Manuela Gencarelli, Costanza Mazzantini, Annunziatina Laurino, Domenico Edoardo Pellegrini-Giampietro, and Laura Raimondi. "N-(3-Ethoxy-phenyl)-4-pyrrolidin-1-yl-3-trifluoromethyl-benzamide (EPPTB) prevents 3-iodothyronamine (T1AM)-induced neuroprotection against kainic acid toxicity." Neurochemistry International 129 (October 2019): 104460. http://dx.doi.org/10.1016/j.neuint.2019.05.004.
Full textHan, Hong-Seok, Hyun-June Paik, Jai Min Ryu, et al. "Comparison of prognosis and specific features according to tumor size in small-sized breast cancer with extensive lymph node involvement." Journal of Clinical Oncology 33, no. 28_suppl (2015): 81. http://dx.doi.org/10.1200/jco.2015.33.28_suppl.81.
Full textLaurino, Annunziatina, Gaetano De Siena, Alessandro Saba, et al. "In the brain of mice, 3-iodothyronamine (T1AM) is converted into 3-iodothyroacetic acid (TA1) and it is included within the signaling network connecting thyroid hormone metabolites with histamine." European Journal of Pharmacology 761 (August 2015): 130–34. http://dx.doi.org/10.1016/j.ejphar.2015.04.038.
Full textVogelsang, Tilman L. R., Aurelia Vattai, Elisa Schmoeckel, et al. "Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer." International Journal of Molecular Sciences 22, no. 16 (2021): 8479. http://dx.doi.org/10.3390/ijms22168479.
Full textDietrich, Johannes W., Patrick Müller, Fabian Schiedat, et al. "Nonthyroidal Illness Syndrome in Cardiac Illness Involves Elevated Concentrations of 3,5-Diiodothyronine and Correlates with Atrial Remodeling." European Thyroid Journal 4, no. 2 (2015): 129–37. http://dx.doi.org/10.1159/000381543.
Full textRathmann, Daniel, Eddy Rijntjes, Julika Lietzow, and Josef Köhrle. "Quantitative Analysis of Thyroid Hormone Metabolites in Cell Culture Samples Using LC-MS/MS." European Thyroid Journal 4, Suppl. 1 (2015): 51–58. http://dx.doi.org/10.1159/000430840.
Full textFehrenbacher, Louis, Angela M. Capra, Charles P. Quesenberry, Regan Fulton, Parveen Shiraz, and Laurel A. Habel. "Distant Invasive Breast Cancer Recurrence Risk in Human Epidermal Growth Factor Receptor 2–Positive T1a and T1b Node-Negative Localized Breast Cancer Diagnosed From 2000 to 2006: A Cohort From an Integrated Health Care Delivery System." Journal of Clinical Oncology 32, no. 20 (2014): 2151–58. http://dx.doi.org/10.1200/jco.2013.52.0858.
Full textKanayama, Naoki, Mitsuyoshi Ueda, Haruyuki Atomi, and Atsuo Tanaka. "Genetic Evaluation of Physiological Functions of Thiolase Isozymes in the n-Alkane-Assimilating YeastCandida tropicalis." Journal of Bacteriology 180, no. 3 (1998): 690–98. http://dx.doi.org/10.1128/jb.180.3.690-698.1998.
Full textOyama, Tsuneo, and Akiko Takahashi. "PS02.025: CHARACTERISTICS OF SUPERFICIAL BASALOID SQUAMOUS CELL CARCINOMA TREATED BY ENDOSCOPIC RESECTION." Diseases of the Esophagus 31, Supplement_1 (2018): 127. http://dx.doi.org/10.1093/dote/doy089.ps02.025.
Full text